Edition:
United States

Chimerix Inc (CMRX.OQ)

CMRX.OQ on NASDAQ Stock Exchange Global Market

4.50USD
26 May 2017
Change (% chg)

$-0.07 (-1.53%)
Prev Close
$4.57
Open
$4.58
Day's High
$4.61
Day's Low
$4.42
Volume
89,288
Avg. Vol
110,478
52-wk High
$6.63
52-wk Low
$3.50

CMRX.OQ

Chart for CMRX.OQ

About

Chimerix, Inc. is a biotechnology company. The Company is focused on discovering, developing and commercializing medicines that address unmet medical needs. Its lead compound, brincidofovir, is in development as an oral and intravenous (IV) formulation for the prevention and treatment of deoxyribonucleic acid (DNA) viruses,... (more)

Overall

Beta: 1.57
Market Cap(Mil.): $209.93
Shares Outstanding(Mil.): 46.65
Dividend: --
Yield (%): --

Financials

  CMRX.OQ Industry Sector
P/E (TTM): -- 137.90 17.41
EPS (TTM): -1.46 -- --
ROI: -23.50 -8.48 -5.42
ROE: -23.53 -11.31 -4.68

BRIEF-Chimerix Q1 loss per share $0.38

* Q1 earnings per share view $-0.36 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

May 09 2017

BRIEF-Chimerix Q4 loss per share $0.32

* Chimerix announces fourth quarter and full year 2016 financial results

Mar 02 2017

More From Around the Web

Competitors

Earnings vs. Estimates